Clik here to view.
Research round-up: AAIC Day One
Alzheimer’s Research UK funded scientists, along with scientists from across the world, have met in Copenhagen to share findings and discuss new ideas in the field of dementia research. Here are some...
View ArticleClik here to view.
Research round-up: AAIC Day Two
Today was the second day of the Alzheimer’s Association International Conference 2014 in Copenhagen, where thousands of dementia researchers have gathered to discuss their latest results. Here is a...
View ArticleClik here to view.
Important discussions at the Alzheimer’s Association International Conference...
The Alzheimer’s Association International Conference 2014 provides the perfect platform for dementia researchers to discuss some of the more controversial, thought-provoking and fascinating issues...
View ArticleIn the news: B vitamins and Alzheimer’s disease
A new analysis of several clinical trials has drawn a conclusion that will dismay many: taking B vitamins does not slow the decline in memory and thinking skills that comes with age. The results...
View ArticleGlobal partnerships to meet the dementia challenge
Eleven more years. That is the G8 summit declaration; a cure or disease-modifying treatment for dementia by 2025. Fortunately, our scientists are not short on the drive or inspiration needed to step-up...
View ArticleClik here to view.
Dementia research in 2014: looking back at our proudest achievements
This time of year is full of lists. Best album, five ways to use your Christmas turkey leftovers, 10 pictures of cats dressed as reindeer…. Hopefully you’ve got room for one more! 2014 has been a year...
View ArticleClik here to view.
Why a diabetes drug may offer potential treatment for Alzheimer’s disease
You may have seen in the news recently the announcement that a drug commonly used to treat type 2 diabetes is to be tested in a clinical trial for Alzheimer’s disease. The study led by scientists at...
View ArticleClik here to view.
Why do some people get dementia and not others?
As the number of people living with dementia grows, so does public awareness of the condition. According to a YouGov poll, dementia is now the most feared condition in over 55s in the UK. But why do...
View ArticleClik here to view.
Dementia: it’s not all about Alzheimer’s or memory
It’s a common misconception that dementia is all about Alzheimer’s and that it’s all about memory loss. Alzheimer’s may be the most common cause of dementia and memory loss one of the most common...
View ArticleDementia researchers are leaving no stone unturned in the hunt for new...
A major goal of dementia research is to find treatments that will benefit the millions of people around the world living with the condition. At this week’s Alzheimer’s Association International...
View ArticleClik here to view.
Dementia in the future: what’s in store for our children?
A new analysis has estimated that for every child born this year, one in three can be expected to develop dementia during their lifetime. The finding is revealed on World Alzheimer’s Day, a date that...
View ArticleClik here to view.
The Alzheimer’s Research UK Drug Discovery Alliance
In February 2015 we launched our £30 million Drug Discovery Alliance. The Drug Discovery Alliance is a network of three Institutes at the Universities of Cambridge and Oxford, and University College...
View ArticleClik here to view.
Two years on from the G8 dementia summit – what progress has been made?
In December 2013 the UK government hosted the G8 dementia summit as part of its G8 presidency. So what has happened since then, and what progress has been made towards meeting the key aim to develop a...
View ArticleClik here to view.
The latest progress towards new dementia treatments
At Alzheimer’s Research UK, we’re committed to funding the most innovative grass-roots research and translating promising discoveries into benefits for people with dementia as quickly as possible. At...
View ArticleJoining forces for the UK’s biggest endeavour in dementia research
Today we are pleased to announce a major new commitment for Alzheimer’s Research UK. Over the next 10 years, the charity will invest £50m into the UK Dementia Research Institute – becoming a founding...
View ArticleClik here to view.
Is Alzheimer’s written in your genes?
Research updates from Alzheimer’s Association International Conference 2016 This week dementia researchers from six continents, hundreds of research institutions and countless different backgrounds...
View ArticleClik here to view.
The immune system – a wolf in sheep’s clothing in Alzheimer’s?
Our immune systems are vital for keeping us healthy. This complex defence mechanism is made up of an army of millions of cells circulating in the blood and patrolling in our tissues. This army is made...
View ArticleClik here to view.
Who is most at risk of dementia?
Dementia is the most feared diagnosis in the over 55s in the UK, affecting around 850,000 people across the country. You often ask us why some people develop the condition and others don’t, and whether...
View ArticleSilver lining for first anti-tau Alzheimer’s treatment in phase III?
Findings were reported today from the first phase III anti-tau drug in people with mild-to-moderate Alzheimer’s. The drug, called LMTM, was being tested in a 15-month double-blind, controlled trial in...
View ArticleClik here to view.
Researching risk reduction
On the blog earlier this week we talked about the latest research to identify the people who are most at risk of dementia. Our age and our genes are two of the biggest risk factors for dementia and, no...
View Article